Tsumura & Co.

4540.T
Drug Manufacturers - Specialty & Generic
2026/09/29 12:05 Updated
Market Cap: $1.8B (¥282.7B)
Stock Price: $24.12 (¥3,792)
Exchange Rate: 1 USD = ¥157.23

Notice of Completion of Shares Acquisition of Yomeishu Seizō Co., Ltd. (Progress Report on Disclosure Matters)

Acquisition of Yomeishu Seizō Co., Ltd. shares completed. Acquisition price: 6.8 billion yen. Consolidated incorporation into results planned from the second quarter of the fiscal year ending March 2027. Impact amount is being examined.

Importance:
Page Updated: September 22, 2026
IR Disclosure Date: September 1, 2026

Key Figures

  • Number of shares acquired: 6 shares
  • Acquisition price: 68 hundred million yen
  • Record date: September 1, 2026

AI要約

Overview of acquiring Yomeishu Seizō Co., Ltd.

This progress report communicates that, as part of a transaction to make Yomeishu Seizō a subsidiary, the shares of Yomeishu Seizō were acquired via Yeazawa Co., Ltd. The acquired shares are 6 (100.0% ownership), and the acquisition value is 6.8 billion yen. The acquisition date is September 1, 2026. Post-acquisition, the company will be a wholly owned subsidiary.

Impact on performance and disclosure

Consolidation of results is scheduled to commence from the second quarter of the fiscal year ending March 2027. At present, the impact amount for the 2027 fiscal year is under examination, and details will be disclosed later. Through strengthening the growth strategy in the health care domain of preventive medicine and health preservation, it is expected to contribute to the long-term management vision.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Tsumura & Co.

Company overview · Stock price · Financial data · All IR

View company page →